Dechezleprêtre S, Lechat P, Wickelholz M
Arch Toxicol. 1975 Dec 18;34(4):309-14. doi: 10.1007/BF00353850.
When given orally in elevated but nonlethal doses (150 to 450 mg/kg, on 2 consecutive days), glafenine induces in rats (body weight 100 g) a transient nephritis with an increase in blood urea, hypertrophy of adrenals, and some changes in the serum proteinogram. These effects do not appear to be due to the 4-amino-7-chloroquinoline structure from which glafenine is derived, as they are not observed with the structural analogue chloroquine given at equimolar doses under the same conditions. Further, they do not appear to be due to glycerol, the by-product of metabolic glafenine hydrolysis. The responsible molecule appears to be either glafenine itself or its acid metabolite 4-(0-carboxyphenylamino) 7-chloroquinoline.
当以升高但非致死剂量(150至450毫克/千克,连续两天)口服时,格拉非宁在大鼠(体重100克)中诱发短暂性肾炎,伴有血尿素升高、肾上腺肥大以及血清蛋白图谱的一些变化。这些效应似乎并非源于格拉非宁所衍生的4-氨基-7-氯喹啉结构,因为在相同条件下给予等摩尔剂量的结构类似物氯喹时未观察到这些效应。此外,它们似乎也不是由于格拉非宁代谢水解的副产物甘油所致。起作用的分子似乎要么是格拉非宁本身,要么是其酸性代谢物4-(邻羧基苯氨基)-7-氯喹啉。